![Matthew Osborne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Osborne
No open positions remaining
Profile
Mr. Matthew S.
Osborne was previously employed as an Investor Relations by Apple Tree Venture Management Llc//vc, a Chief Financial Officer by Senda Biosciences, Inc., a Chief Financial Officer by Oncxerna Therapeutics, Inc., a Chief Financial Officer by Unum Therapeutics, Inc., a Chief Financial Officer by Unum Therapeutics, Inc., a VP-Investor Relations & Corporate Communications by Voyager Therapeutics, Inc., a Head-Investor Relations by Shire Plc, a Vice President-Investor Relations by Synageva BioPharma Corp., a Vice President by FM Partners Holdings LLC, an Associate Analyst by SVB Securities LLC, a Vice President by C.
E.
Unterberg, Towbin, Inc., a Salesman by Genzyme Corp., and a Head-Investor Relations by Vertex Pharmaceuticals, Inc. He received his undergraduate degree from Syracuse University and an MBA from D'Amore-Mckim School of Business.
Former positions of Matthew Osborne
| Companies | Position | End |
|---|---|---|
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Public Communications Contact | 2024-08-30 |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Director of Finance/CFO | 2022-09-30 |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Director of Finance/CFO | 2021-05-31 |
| COGENT BIOSCIENCES, INC. | Director of Finance/CFO | 2020-05-31 |
| COGENT BIOSCIENCES, INC. | Director of Finance/CFO | 2020-05-28 |
Training of Matthew Osborne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
C. E. Unterberg, Towbin, Inc.
 C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance Provides investment bank services in the technology, healthcare, and security/crime control/anti-terrorism industries | Finance |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
D'Amore-Mckim School of Business
 D'Amore-Mckim School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
- Stock Market
- Insiders
- Matthew Osborne
